Article

Second-line erlotinib for non-small-cell lung cancer

Medical Oncology Unit, Ospedale Vito Fazzi, Lecce, Italy.
The Lancet Oncology (Impact Factor: 24.73). 04/2012; 13(4):e141-2; author reply e142. DOI: 10.1016/S1470-2045(12)70113-4
Source: PubMed
0 Followers
 · 
162 Views